4 completed, 1 unknown. 2 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Schizophrenia, Disorganized: new trials by email Literature Review of Schizophrenia, Disorganized trials Research Report on Schizophrenia, Disorganized
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia psyllium husk - Overweight and Obesity, Metabolic Cardiovascular Syndrome | Not applicable | Completed | Ru-Shin Zhang | 24 | 2024-05-01 | 2025-01-23 |
| Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) asenapine - Schizophrenia, Paranoid, Schizophrenia, Disorganized | Phase 3 | Completed | Organon and Co | 204 | 2010-09-28 | 2024-05-22 |
| Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) asenapine 2.5 mg, asenapine 5.0 mg, placebo - Schizophrenia, Paranoid, Schizophrenia, Disorganized | Phase 3 | Completed | Organon and Co | 306 | 2010-09-28 | 2024-05-21 |
| Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia t-VNS verum, t-VNS placebo - Schizophrenia | Phase 2 | Completed | cerbomed GmbH | 20 | 2010-03-01 | 2012-09-12 |
| Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone Long-acting Risperidone microspheres injection - Schizophrenia, Catatonic, Schizophrenia, Disorganized | Not applicable | Unknown | Hospital Authority, Hong Kong | 30 | 2004-10-01 | 2010-07-07 |
Schizophrenia (4) · Schizophrenia, Paranoid (4) · Disorders of Sex Development (2) · Psychotic Disorders (2) · Schizophrenia, Catatonic (2) · Delusions (1) · Dementia (1) · Hallucinations (1) · Illusions (1) · Mental Disorders (1) · Metabolic Syndrome (1) · Neuroleptic Malignant Syndrome (1) · Obesity (1) · Overweight (1)
Schizophrenia Spectrum and Other Psychotic Disorders (5) · Mental Disorders (4) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gonadal Disorders (2) · Male Urogenital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urogenital Abnormalities (2) · Urogenital Diseases (2) · Basal Ganglia Diseases (1) · Behavior (1)
Organon and Co (2) · Hospital Authority, Hong Kong (1) · Ru-Shin Zhang (1) · cerbomed GmbH (1)
China (1) · Germany (1) · Taiwan (1)
Mei-Ling Lin (1) · Wing King Lee, Dr (1)
2009 (2)